HIV Management in Women and Infants During the Perinatal Period


Zoom login details:
You are invited to a Zoom webinar!
When: Friday May 2nd, 2025     1:30 pm EST
Topic: Spring 2025 HUCOP Clinical Rounds_ "Free CE" Webinar Series
Presentation entitled, "HIV Management in Women and Infants During the Perinatal Period"
Speaker: Dr. Milan Scott
Join from PC, Mac, iPad, or Android:
https://howard.zoom.us/j/84396365474
Phone one-tap:
+16465588656,,84396365474# US (New York)
+16469313860,,84396365474# US

Join via audio:
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 669 444 9171 US
Webinar ID: 843 9636 5474
International numbers available: https://howard.zoom.us/u/kd5teMPazL


Join from an H.323/SIP room system:
H.323:
144.195.19.161 (US West)
206.247.11.121 (US East)
115.114.131.7 (India Mumbai)
115.114.115.7 (India Hyderabad)
159.124.15.191 (Amsterdam Netherlands)
159.124.47.249 (Germany)
159.124.104.213 (Australia Sydney)
159.124.74.212 (Australia Melbourne)
170.114.180.219 (Singapore)
64.211.144.160 (Brazil)
159.124.132.243 (Mexico)
159.124.168.213 (Canada Toronto)
159.124.196.25 (Canada Vancouver)
170.114.194.163 (Japan Tokyo)
147.124.100.25 (Japan Osaka)
Meeting ID: 843 9636 5474
SIP: 84396365474@zoomcrc.com

Date: May 2, 2025 01:30 PM - 02:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on May 09, 2025 10:00 PM

Activity Type

Application

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

Objectives

  • Determine the importance of antepartum management, focusing on transmission risk assessment and medication management for antiretroviral therapy-naive mothers.
  • Evaluate the significance of intrapartum care and methods to reduce the risk of mother-to-child transmission.
  • Outline the management strategies during the postpartum phase, including the care of infected infants and antiretroviral therapy selection during breastfeeding.
  • Summarize pharmacokinetic changes in pregnancy, focusing on the passage of key antiretroviral medications through the placenta and breast milk.

Speaker(s)/Author(s)

Dr. Milan Scott

Activity Number

0010-0000-25-032-L02-P
Date: 05/02/25
Time: 01:30 PM - 02:30 PM

CE Hours

1.00